Publications Office of the EU
Malta-Floriana: Various medicinal products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Malta-Floriana: Various medicinal products

Overview
  • Published
    19/10/2023
  • Deadline
    16/11/2023
  • Opening of tenders
    16/11/2023
  • Today
    16/07/2026
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Department of Contracts
Place of performance
NUTS code: MT00 Malta
Location of buyer
NUTS code: MT Malta
Business sector (Main CPV)
33690000 Various medicinal products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
Not available
Description

CT2262/2023 - Tender for the supply of Belimumab solution for injection in pre-filled pen or syringe 200mg

Submission Method
Electronic via:
https://www.etenders.gov.mt/epps/cft/prepareViewCfTWS.do?resourceId=10523309
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
16/11/2023 10:00
Place of performance
MT00 Malta
CPV code

33690000 - Various medicinal products

Award method
Lowest price
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.